Biosynex (FRA:0DL) Total Liabilities : €105.5 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biosynex Total Liabilities?

Biosynex's Total Liabilities for the quarter that ended in Jun. 2024 was €105.5 Mil.

Biosynex's quarterly Total Liabilities declined from Jun. 2023 (€129.68 Mil) to Dec. 2023 (€117.41 Mil) and declined from Dec. 2023 (€117.41 Mil) to Jun. 2024 (€105.54 Mil).

Biosynex's annual Total Liabilities declined from Dec. 2021 (€101.14 Mil) to Dec. 2022 (€93.45 Mil) but then increased from Dec. 2022 (€93.45 Mil) to Dec. 2023 (€117.41 Mil).

Biosynex Total Liabilities Historical Data

The historical data trend for Biosynex's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosynex Total Liabilities Chart

Biosynex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

16.48

59.79

101.14

93.45

117.41

Biosynex Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial															73.62	93.45	129.68	117.41	105.54

Biosynex Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biosynex's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	40.821	+	(59.576	+	17.017
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	117.4

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	241.729	-	124.315
	=	117.4

Biosynex's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	85.836	+	(10.523	+	9.184
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	105.5

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	208.754	-	103.211
	=	105.5

Biosynex Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biosynex's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosynex Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biosynex SA (FRA:0DL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ALBIO:France

Address

22 Boulevard Sebastien Brant, Illkirch, FRA, 67400

Website

http://www.biosynex.com

Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.

Biosynex Headlines

No Headlines